Rein Therapeutics, Inc.
RNTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001420565
No open-market purchases or sales by Rein Therapeutics, Inc. insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $42.5M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Rein Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Rein Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Von Rickenbach Josef H | Director | 62,514 | May 28, 2026 | 1 |
| Windsor James Brian | See Remarks | 27,046 | May 13, 2026 | 1 |
| Voss Capital, LP | 10% Owner | 926,441Indirect | Nov 18, 2025 | 2 |
| Voss Advisors GP, LLC | 10% Owner | 926,441Indirect | Nov 18, 2025 | 2 |
| Cocke Travis W. | 10% Owner | 926,441Indirect | Nov 18, 2025 | 2 |
| Voss Value-Oriented Special Situations Fund, LP | 10% Owner | 926,441Indirect | Nov 18, 2025 | 2 |
| Voss Value Master Fund, LP | 10% Owner | 926,441Indirect | Nov 18, 2025 | 2 |
| Musso Alan A | Director | – | Jul 23, 2025 | 0 |
| Aivado Manuel | Director | – | Jul 23, 2025 | 0 |
| Ambros Reinhard J. | Director | – | Jul 23, 2025 | 0 |
| Fairey William | Director | – | Jul 23, 2025 | 0 |
| University Of Texas/Texas Am Investment Management Co | 10% Owner | 1,746,549 | Jun 17, 2024 | 0 |
| McKee William | Director | – | Jun 17, 2022 | 0 |
| Sigal Nolan Howard | Director | – | Jun 17, 2022 | 0 |
| Bailey Jeffrey Allen | Director | – | Jun 17, 2022 | 0 |
| Morrison Jodie Pope | Director | – | Jun 17, 2022 | 0 |
| Vukovic Vojo | Chief Medical Officer | – | Mar 30, 2022 | 0 |
| Annis Allen | SVP, Research | – | Mar 30, 2022 | 0 |
| Wanstall Rick | See Remarks | – | Mar 30, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 28, 2026 (view filing) | May 21-27 | 7 daysLate | Von Rickenbach Josef HDirector | PPurchaseCommon stock , $0.001 par value | +47.1K | $1.06 | +$49.7K | +304.5%62.5K after | 4 lots |
| May 13, 2026 (view filing) | Apr 30 | 13 daysLate | Windsor James BrianSee Remarks | PPurchaseCommon stock , $0.001 par value | +25.0K | $1.00 | +$25.0K | +1,221.9%27.0K after | |
| Nov 18, 2025 (view filing)5:30 PM ET | Nov 14 | 4 days | Voss Capital, LP and 4 others10% Owner | PPurchaseCommon Stock, $0.001 par value | +104.2K | $1.22 | +$127.6K | +12.7%926.4K after | |
| Oct 28, 2025 (view filing)6:45 PM ET | Oct 24-28 | 4 days | Voss Capital, LP and 4 others10% Owner | PPurchaseCommon Stock, $0.001 par value | +306.1K | $1.38 | +$423.5K | +157.8%500.0K after | 4 lots |
| Dec 9, 2024 (view filing) | Dec 5 | 4 days | Windsor James BrianPresident and CEO | PPurchase | +400 | $2.24 | +$897.61 | New position161 after | 2 lots |
| Jun 17, 2024 (view filing) | Jun 14-17 | 3 days | University Of Texas/Texas Am Investment Management Co10% Owner | SSale | −6.61K | $3.26 | −$21.6K | −0.4%1.75M after | 2 lots |
| Jun 12, 2024 (view filing) | Jun 10-12 | 2 days | University Of Texas/Texas Am Investment Management Co10% Owner | SSale | −24.7K | $3.27 | −$80.7K | −1.4%1.75M after | 5 lots |
| Jun 7, 2024 (view filing) | Jun 5-7 | 2 days | University Of Texas/Texas Am Investment Management Co10% Owner | SSale | −12.3K | $3.29 | −$40.5K | −0.7%1.78M after | 5 lots |
| May 14, 2024 (view filing) | May 1 | 13 days | University Of Texas/Texas Am Investment Management Co10% Owner | SSale | −20.3K | $4.21 | −$85.5K | −1.1%1.79M after | Amended16 lots |
| Dec 18, 2023 (view filing) | Dec 15 | 3 days | Windsor James BrianPresident and COO | PPurchase | +225 | $3.37 | +$758.25 | New position225 after | |
| Nov 21, 2023 (view filing) | Nov 20 | 1 day | Windsor James BrianPresident and COO | PPurchase | +5.08K | $1.97 | +$10.0K | +11,034.8%5.12K after |